V.02.2 Endoscopic Ultrasound Guided Radiofrequency Ablation of a Pancreatic Neuroendocrine Tumour (With Video)

Armellini, Elia; Crinò, S.F.; Ballarè, M.; Leutner, Monica; Occhipinti, Pietro

doi:10.1016/s1590-8658(16)30136-0

Cited by 2 publications

(6 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, using percutaneous or EUS guidance, a safe mini-invasive approach can be obtained avoiding laparotomy. To the best of our knowledge, 10 patients underwent pancreatic EUS-RFA with the EUSRA electrode without severe adverse events and with high technical success [5,[18][19][20]. The results of our series confirm the feasibility, safety and local thermal effect of the procedure.…”

Section: Discussionsupporting

confidence: 69%

See 1 more Smart Citation

EUS-guided Radiofrequency Ablation (EUS-RFA) of Solid Pancreatic Neoplasm Using an 18-gauge Needle Electrode: Feasibility, Safety, and Technical Success

Crinò¹,

D’Onofrio

Bernardoni³

et al. 2018

JGLD

View full text Add to dashboard Cite

Background & Aims: Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) is a promising technique for the treatment of pancreatic neoplasm. We evaluated the feasibility, safety, and technical success of pancreatic EUS-RFA performed in a single center.Methods: 9 consecutive patients (8 with pancreatic adenocarcinoma and 1 with renal cancer metastasis) were referred for EUS-RFA between November 2016 and July 2017. EUS-RFA was performed using 18-gauge internally cooled electrode with a 5 or 10 mm exposed tip. Feasibility, technical success or early and late adverse events were assessed.Results: One patient was excluded because of a large necrotic portion. EUS-RFA was feasible in all the other 8 (100%) cases. An ablated area inside the tumor was achieved in all treated patients. No early or late major adverse event was observed after a mean follow-up of 6 months. Three patients experienced mild postprocedural abdominal pain.Conclusions: EUS-RFA seems a feasible, safe, and effective procedure for pancreatic neoplasms. Its role in the treatment and management of pancreatic masses must be further investigated.

show abstract

Section: Discussionsupporting

confidence: 69%

“…First, EUS-RFA can be included in multimodality treatment protocols for locally advanced PDAC. Second, EUS-RFA could represent a possible treatment for pancreatic solid lesions in patients unfit for surgery due to comorbidities, or for patients who refuse surgery [19].…”

Section: Discussionmentioning

confidence: 99%

EUS-guided Radiofrequency Ablation (EUS-RFA) of Solid Pancreatic Neoplasm Using an 18-gauge Needle Electrode: Feasibility, Safety, and Technical Success

Crinò¹,

D’Onofrio

Bernardoni³

et al. 2018

JGLD

View full text Add to dashboard Cite

show abstract

“…It is essential to highlight that, within this context, around 90% of insulinomas appear as single lesions, generally benign and small (< 2 cm), which can be located in different regions of the pancreas (MARX M. et al, 2022;YUAN T. et al, 2021). However, between 5% and 10% of these tumors may be associated with Type I Multiple Endocrine Neoplasia, a condition that is related to less favorable prognoses (CRINÒ S.F. et al, 2023).…”

Section: Introductionmentioning

confidence: 99%

“…Conventional treatment of insulinoma involves surgical resection of the affected pancreatic tissue, an effective intervention, but associated with a significant rate of adverse events (AEs) (CRINÒ S.F. et al, 2023).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Critical Topics in the Clinical and Therapeutic Approach to Insulinoma: A Comprehensive Review to Improve Care and Management

Koshikumo,

Sollis,

Leandro

et al. 2024

JHS

View full text Add to dashboard Cite

Objective: The purpose of this literature review article is to analyze the challenges related to insulinoma, providing relevant insights into the clinical approach to these patients. Methodology: An integrative review was carried out using the PubMed database. The initial search resulted in 191 articles, of which, after applying inclusion and exclusion criteria, 12 were selected to compose the present work. Results: Studies indicate that insulinoma is a pancreatic neuroendocrine tumor associated with hypoglycemia. Endoscopic ultrasound has emerged as the most effective diagnostic method for its detection, with emphasis on its integration into the preoperative routine due to its high diagnostic value. Radical surgical resection stands out as the main treatment option, highlighting the importance of precisely identifying the location of the insulinoma before surgical intervention, aiming to increase the success rate and reduce the risk of complications. Final Considerations: This study highlights the persistence of challenges in the management of these patients, resulting both from the absence of neurogenic and neuroglycopenic symptoms and the lack of early screening for insulinomas.

show abstract

V.02.2 Endoscopic Ultrasound Guided Radiofrequency Ablation of a Pancreatic Neuroendocrine Tumour (With Video)

Cited by 2 publications

References 0 publications

EUS-guided Radiofrequency Ablation (EUS-RFA) of Solid Pancreatic Neoplasm Using an 18-gauge Needle Electrode: Feasibility, Safety, and Technical Success

EUS-guided Radiofrequency Ablation (EUS-RFA) of Solid Pancreatic Neoplasm Using an 18-gauge Needle Electrode: Feasibility, Safety, and Technical Success

Critical Topics in the Clinical and Therapeutic Approach to Insulinoma: A Comprehensive Review to Improve Care and Management

Contact Info

Product

Resources

About